-
Prilenia’s Application for European Approval of Pridopidine Withdrawn
Latest News
-
No surprises in published results from HART study of Huntexil for Huntington's disease
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
-
Liver changes in Huntington's disease patients suggest more 'whole body' research needed
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-
The 'N17' region of huntingtin protein: an address label in Huntington's disease?
New research sheds light on where the huntingtin protein ends up inside our cells, and why
-
HDBuzz Special Feature: Huntington's disease and sleep
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?
-
The University of New Orleans has NOT discovered a cure for Huntington's disease
The science behind an extraordinary press release claiming to have discovered 'A Way to Delay Symptoms of HD'
-
Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
'Discovery-driven' screen reveals new protein networks involved in Huntington's disease damage & new drug targets
-
Prana Biotech publishes Huntington's disease animal model data for PBT2
Prana Biotechnology has released data demonstrating their drug, PBT2, is effective in animal models of HD
-
'Guard dog' proteins reveal surprising connections between Huntington's disease and other brain disorders
DNA/RNA-binding proteins may be involved in the damage caused by Huntington's disease and other major brain disorders
-
Dyeing to prevent dying? Methylene blue beneficial in Huntington's disease mice
A bolt from the blue – methylene blue may fight Huntington's disease by preventing protein clumps
-
Prominent Huntington's disease researcher "fabricated data" in grant applications
Noted Huntington's disease researcher found to have falsified data on grant applications – but published findings sta
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
